tetano
Editor, Senior Moderator
Cureus
. 2021 Nov 25;13(11):e19885.
doi: 10.7759/cureus.19885. eCollection 2021 Nov.
Cerebral Venous Sinus Thrombosis in a Patient With Mild Symptoms of COVID-19 Pneumonia
Asad Chohan[SUP] 1 [/SUP], Farah Chohan[SUP] 2 [/SUP], Pedram Rad[SUP] 2 [/SUP], George Michel[SUP] 2 [/SUP], George Yatzkan[SUP] 3 [/SUP]
Affiliations
Abstract
Although coronavirus disease 2019 (COVID-19) infection is mainly associated with pneumonia, several non-respiratory complications may also occur. Cerebral venous sinus thrombosis (CVST) is a rare but potentially fatal complication of COVID-19 infection. In order to increase awareness about such life-threatening complications to a large population of patients with otherwise mild COVID-19 infection, we present the clinical course of a 29-year-old unvaccinated female who developed CVST, with eight days of mild COVID-19 infection, that proved fatal despite adequate therapeutic measures. Clinicians should carefully consider the risk of thrombosis in patients who present with COVID-19 infection regardless of the intensity of the disease, including prophylaxis (to reduce the risk of hypercoagulable complications) and treatment beyond discharge. More data and research is needed to identify COVID-19 as an independent risk factor for thromboembolism so that future efforts can be aimed at appropriate management e.g. with prophylactic anticoagulants to avoid such complications. In case of unexplained neurological manifestations in patients with an active or recent COVID-19 infection, early investigations for cerebrovascular integrity should be done by using MRI and magnetic resonance angiography (MRA)/magnetic resonance venography (MRV).
Keywords: covid-19; cvst; pneumonia; sars-cov-2; thromboembolism.
. 2021 Nov 25;13(11):e19885.
doi: 10.7759/cureus.19885. eCollection 2021 Nov.
Cerebral Venous Sinus Thrombosis in a Patient With Mild Symptoms of COVID-19 Pneumonia
Asad Chohan[SUP] 1 [/SUP], Farah Chohan[SUP] 2 [/SUP], Pedram Rad[SUP] 2 [/SUP], George Michel[SUP] 2 [/SUP], George Yatzkan[SUP] 3 [/SUP]
Affiliations
- PMID: 34966603
- PMCID: PMC8710035
- DOI: 10.7759/cureus.19885
Abstract
Although coronavirus disease 2019 (COVID-19) infection is mainly associated with pneumonia, several non-respiratory complications may also occur. Cerebral venous sinus thrombosis (CVST) is a rare but potentially fatal complication of COVID-19 infection. In order to increase awareness about such life-threatening complications to a large population of patients with otherwise mild COVID-19 infection, we present the clinical course of a 29-year-old unvaccinated female who developed CVST, with eight days of mild COVID-19 infection, that proved fatal despite adequate therapeutic measures. Clinicians should carefully consider the risk of thrombosis in patients who present with COVID-19 infection regardless of the intensity of the disease, including prophylaxis (to reduce the risk of hypercoagulable complications) and treatment beyond discharge. More data and research is needed to identify COVID-19 as an independent risk factor for thromboembolism so that future efforts can be aimed at appropriate management e.g. with prophylactic anticoagulants to avoid such complications. In case of unexplained neurological manifestations in patients with an active or recent COVID-19 infection, early investigations for cerebrovascular integrity should be done by using MRI and magnetic resonance angiography (MRA)/magnetic resonance venography (MRV).
Keywords: covid-19; cvst; pneumonia; sars-cov-2; thromboembolism.
